Skip to main content
Top
Gepubliceerd in: Quality of Life Research 9/2021

08-04-2021

Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy

Auteurs: Ivo Bozovic, Marina Peric, Ana Arsic Azanjac, Aleksa Palibrk, Ivana Bulatovic, Dejan Aleksic, Stojan Peric, Ivana Basta

Gepubliceerd in: Quality of Life Research | Uitgave 9/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Even treated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) continues to pose a significant burden in patients’ everyday functioning and may continuously affect their quality of life (QoL). The aims of our prospective study were to analyze health-related QoL in CIDP patients during a 1-year follow-up period in real-life settings and to compare QoL changes with changes in disability and with patient impression of change.

Methods

The study comprised 59 patients diagnosed with CIDP. SF-36 questionnaire was applied in order to evaluate patients’ QoL. Inflammatory neuropathy cause and treatment (INCAT) disability scale was used to assess patients’ functionality. The second question from the SF-36 questionnaire was used as an estimation of the patient impression of change (PIC) after 1 year.

Results

SF-36 scores did not change over time in the group as a whole. According to INCAT disability scores, worsening was registered in 24 (40%) patients and improvement in 8 (14%). Fifteen (25%) patients reported worsening and the same number reported improvement, according to PIC. Concordant results on INCAT and PIC were registered in 49% of patients. Pooled SF-36 scores moderately correlated with pooled INCAT disability scores (rho = − 0.27 to − 0.59, p < 0.01). One-year changes of SF-36 scores did not differ when compared to different INCAT outcomes (worsening, stable, improvement). On the other hand, significant changes of SF-36 scores in different outcome groups according to PIC (worsening, stable, improvement) were noted (p < 0.01).

Conclusion

INCAT, PIC, and SF-36 are complementary outcome measures that provide neurologists with useful items of information. We propose complementary use of these scales in CIDP patients in everyday clinical practice in order to detect worsening of the disease and/or of related symptoms on time.
Literatuur
1.
go back to reference Van den Bergh, P. Y. K., Hadden, R. D. M., Bouche, P., Cornblath, D. R., Hahn, A., Illa, I., et al. (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher. European Journal of Neurology, 17(3), 356–363.CrossRef Van den Bergh, P. Y. K., Hadden, R. D. M., Bouche, P., Cornblath, D. R., Hahn, A., Illa, I., et al. (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripher. European Journal of Neurology, 17(3), 356–363.CrossRef
2.
go back to reference Mayo, E. N. (2015). ISOQOL dictionary of quality of life and health outcomes measurement. International Society for Quality of Life Research. Mayo, E. N. (2015). ISOQOL dictionary of quality of life and health outcomes measurement. International Society for Quality of Life Research.
3.
go back to reference Bozovic, I., Kacar, A., Peric, S., Nikolic, A., Bjelica, B., Cobeljic, M., et al. (2017). Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neurology, 264(12), 2481–2486.CrossRef Bozovic, I., Kacar, A., Peric, S., Nikolic, A., Bjelica, B., Cobeljic, M., et al. (2017). Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of Neurology, 264(12), 2481–2486.CrossRef
4.
go back to reference Merkies, I. S., Schmitz, P. I., van der Meché, F. G., Samijn, J. P., van Doorn, P. A., & Inflammatory Neuropathy Cause and Treatment (INCAT) group. (2002). Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology, 59(1), 84–91.CrossRef Merkies, I. S., Schmitz, P. I., van der Meché, F. G., Samijn, J. P., van Doorn, P. A., & Inflammatory Neuropathy Cause and Treatment (INCAT) group. (2002). Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology, 59(1), 84–91.CrossRef
5.
go back to reference Harbo, T., Andersen, H., Overgaard, K., & Jakobsen, J. (2008). Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 13(3), 208–217.CrossRef Harbo, T., Andersen, H., Overgaard, K., & Jakobsen, J. (2008). Muscle performance relates to physical function and quality of life in long-term chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 13(3), 208–217.CrossRef
6.
go back to reference Westblad, M. E., Forsberg, A., & Press, R. (2009). Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disability and Rehabilitation, 31(9), 720–725.CrossRef Westblad, M. E., Forsberg, A., & Press, R. (2009). Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Disability and Rehabilitation, 31(9), 720–725.CrossRef
7.
go back to reference Erdmann, P. G., van Meeteren, N. L. U., Kalmijn, S., Wokke, J. H. J., Helders, P. J. M., & van den Berg, L. H. (2005). Functional health status of patients with chronic inflammatory neuropathies. Journal of the Peripheral Nervous System, 10(2), 181–189.CrossRef Erdmann, P. G., van Meeteren, N. L. U., Kalmijn, S., Wokke, J. H. J., Helders, P. J. M., & van den Berg, L. H. (2005). Functional health status of patients with chronic inflammatory neuropathies. Journal of the Peripheral Nervous System, 10(2), 181–189.CrossRef
8.
go back to reference dos Santos, P. L., de Almeida-Ribeiro, G. A. N., Silva, D. M. D., Marques Junior, W., & Barreira, A. A. (2014). Chronic inflammatory demyelinating polyneuropathy: Quality of life, sociodemographic profile and physical complaints. Arquivos de Neuro-Psiquiatria, 72(3), 179–183.CrossRef dos Santos, P. L., de Almeida-Ribeiro, G. A. N., Silva, D. M. D., Marques Junior, W., & Barreira, A. A. (2014). Chronic inflammatory demyelinating polyneuropathy: Quality of life, sociodemographic profile and physical complaints. Arquivos de Neuro-Psiquiatria, 72(3), 179–183.CrossRef
9.
go back to reference Merkies, I. S. J., & Kieseier, B. C. (2016). Fatigue, pain, anxiety and depression in Guillain-Barré Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. European Neurology, 75(3–4), 199–206.CrossRef Merkies, I. S. J., & Kieseier, B. C. (2016). Fatigue, pain, anxiety and depression in Guillain-Barré Syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. European Neurology, 75(3–4), 199–206.CrossRef
10.
go back to reference Goebel, A., Lecky, B., Smith, L. J., & Lunn, M. P. (2012). Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 46(2), 294–295.CrossRef Goebel, A., Lecky, B., Smith, L. J., & Lunn, M. P. (2012). Pain intensity and distribution in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 46(2), 294–295.CrossRef
11.
go back to reference Kacar, A., Bjelica, B., Bozovic, I., Peric, S., Nikolic, A., Cobeljic, M., et al. (2018). Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 23(1), 11–16.CrossRef Kacar, A., Bjelica, B., Bozovic, I., Peric, S., Nikolic, A., Cobeljic, M., et al. (2018). Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 23(1), 11–16.CrossRef
12.
go back to reference Merkies, I. S., Bril, V., Dalakas, M. C., Deng, C., Donofrio, P., Hanna, K., et al. (2009). Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study. Neurology, 72(15), 1337–1344.CrossRef Merkies, I. S., Bril, V., Dalakas, M. C., Deng, C., Donofrio, P., Hanna, K., et al. (2009). Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study. Neurology, 72(15), 1337–1344.CrossRef
13.
go back to reference Kleyweg, R. P., van der Meché, F. G., & Schmitz, P. I. (1991). Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle and Nerve, 14(11), 1103–1109.CrossRef Kleyweg, R. P., van der Meché, F. G., & Schmitz, P. I. (1991). Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle and Nerve, 14(11), 1103–1109.CrossRef
14.
go back to reference Breiner, A., Barnett, C., & Bril, V. (2014). INCAT disability score: A critical analysis of its measurement properties. Muscle and Nerve, 50(2), 164–169.CrossRef Breiner, A., Barnett, C., & Bril, V. (2014). INCAT disability score: A critical analysis of its measurement properties. Muscle and Nerve, 50(2), 164–169.CrossRef
16.
go back to reference Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37–46.CrossRef Cohen, J. (1960). A coefficient of agreement for nominal scales. Educational and Psychological Measurement, 20, 37–46.CrossRef
17.
go back to reference Bjelica, B., Peric, S., Bozovic, I., Kacar, A., Cobeljic, M., Dejanovic, I., et al. (2019). One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 24(2), 180–186.CrossRef Bjelica, B., Peric, S., Bozovic, I., Kacar, A., Cobeljic, M., Dejanovic, I., et al. (2019). One-year follow-up study of neuropathic pain in chronic inflammatory demyelinating polyradiculoneuropathy. Journal of the Peripheral Nervous System, 24(2), 180–186.CrossRef
19.
go back to reference Merkies, I. S. J., van Nes, S. I., Hanna, K., Hughes, R. A. C., & Deng, C. (2010). Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: Shifting from statistical significance to clinical relevance. Journal of Neurology, Neurosurgery and Psychiatry, 81(11), 1194–1199.CrossRef Merkies, I. S. J., van Nes, S. I., Hanna, K., Hughes, R. A. C., & Deng, C. (2010). Confirming the efficacy of intravenous immunoglobulin in CIDP through minimum clinically important differences: Shifting from statistical significance to clinical relevance. Journal of Neurology, Neurosurgery and Psychiatry, 81(11), 1194–1199.CrossRef
20.
go back to reference Lawley, A., Abbas, A., Seri, S., & Rajabally, Y. A. (2020). Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 62(2), 226–232.CrossRef Lawley, A., Abbas, A., Seri, S., & Rajabally, Y. A. (2020). Clinical correlates of fatigue in chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve, 62(2), 226–232.CrossRef
Metagegevens
Titel
Prospective analysis of disability and quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy
Auteurs
Ivo Bozovic
Marina Peric
Ana Arsic Azanjac
Aleksa Palibrk
Ivana Bulatovic
Dejan Aleksic
Stojan Peric
Ivana Basta
Publicatiedatum
08-04-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 9/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02838-w

Andere artikelen Uitgave 9/2021

Quality of Life Research 9/2021 Naar de uitgave